Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm in-licenses treatment for rare joint disease

Nov 22, 2018 at 2:57 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment